Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Scientists identify key role of T-bet in flu memory B cells July 11, 2025 Republicans fret over RFK Jr.’s anti-vaccine policies while MAHA moms stew March 12, 2026 Hormonal steroids could make gonorrhea untreatable February 8, 2024